Vala Sciences

What Vala Sciences does

Vala Sciences is a San Diego-based life-sciences tools company founded in 2004 that builds high-content kinetic screening technologies for drug discovery and preclinical safety assessment. The company's core hardware platform is the IC200-KIC® Kinetic Image Cytometer, which captures time-resolved cellular signals at single-cell resolution, paired with CyteSeer® software for image analysis and ValaSIM™ for low-phototoxicity 3D imaging of organoids and complex cell models. ValaDATE.AI™ serves as the company's AI-powered analytics layer, integrated with the proph𝔼CG™ assay to deliver cardiotoxicity prediction for drug safety screening. The company targets pharmaceutical and biotech researchers conducting drug discovery, disease modeling, and preclinical efficacy and safety programs, with use cases spanning cardiac safety screening, neurotoxicity screening, and neurodegenerative disease modeling.

Vala Sciences generates revenue through three streams: capital equipment sales (KIC instruments), software licensing (CyteSeer, ValaSIM), and contract research services spanning cardiac safety screening, neuroscience applications, and high-content analysis. The company also distributes antibodies and reagents as consumables. Go-to-market is enterprise field sales with direct engagement of researchers and pharmaceutical clients, supplemented by a direct website with e-commerce/contact-inquiry capability. The firm operates KIC® Global Research Centers of Excellence, indicating an international service footprint beyond its single San Diego headquarters.

The company is privately held with no disclosed funding rounds, parent company, or institutional investors, and is led by founder Jeffrey H. Price (President and CEO) alongside Chief Research Officer Patrick M. McDonough. Headcount is in the 11-50 range. No revenue, customer counts, partnership agreements, or certification/compliance credentials are disclosed in the available data, and the competitive moat rests on a vertically integrated branded platform (five registered trademarks), proprietary kinetic imaging datasets accumulated over two decades, and switching costs tied to validated assay workflows.

Name

Vala Sciences

Legal name

Vala Sciences

Website

https://valasciences.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Vala Sciences is a privately held San Diego life-sciences tools company that sells a high-content kinetic imaging platform (KIC®), analysis software (CyteSeer®, ValaSIM™), and AI-powered analytics (ValaDATE.AI™), plus contract research services, to pharmaceutical and biotech researchers for preclinical drug safety and efficacy screening.

Ownership category

akta.pro rank

Product category

High-Content Imaging Systems

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Other Scientific and Technical Consulting Services (54169)

SIC

Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industry

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• High-content screening
• Kinetic imaging cytometry
• Drug safety screening
• Cardiotoxicity prediction
• Contract research services

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instruments and Hardware Sales: Sale of high-value scientific instruments including the IC200-KIC® Kinetic Image Cytometer system
2. Software Licenses: Licensing of proprietary software including CyteSeer® and ValaSIM™ for image analysis and cellular analysis
3. Contract Research Services: Providing specialized contract research services including cardiac safety screening, neuroscience applications, and high-content analysis for pharmaceutical and biotech clients

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Vala Sciences develops, manufactures, and sells high-content kinetic screening instruments and software, and provides contract research services for pharmaceutical and biotech researchers. The core product is the IC200-KIC Kinetic Image Cytometer paired with the CyteSeer, ValaSIM, and ValaDATE.AI software platforms, along with the proph𝔼CG assay for cardiotoxicity prediction. The company also offers outsourced cardiac safety, neuroscience, and high-content analysis services through its KIC Global Research Centers of Excellence.

Product overview

Vala Sciences offers a unified portfolio of high-content kinetic screening technologies comprising instruments, software, and AI platforms, complemented by contract research services. The core hardware is the IC200-KIC Kinetic Image Cytometer, which captures kinetic (time-resolved) cellular signals at single-cell resolution. This instrument is paired with CyteSeer Software for advanced single-cell image analysis and ValaSIM for high-resolution low-phototoxicity 3D imaging of organoids. ValaDATE.AI serves as the AI-powered analytical platform that transforms the captured kinetic data into actionable drug discovery insights, while the proph𝔼CG assay enhances cardiotoxicity screening accuracy. Beyond product sales, Vala Sciences operates contract research services spanning cardiac safety screening (using ValaDATE.AI with proph𝔼CG), neuroscience applications for neurodegenerative disease modeling, and general high-content analysis — allowing clients to access the platform throughCRO services without purchasing instruments.

Differentiator

Problem solved

Functional benefit

Brands

• KIC®: Kinetic Image Cytometer IC200-KIC® sets the standard in high-content imaging, capturing subtle disease effects with single-cell precision.
• CyteSeer®
• ValaSIM™
• ValaDATE.AI™
• proph𝔼CG™

Products and services

• IC200-KIC Kinetic Image Cytometer Hardware instrument (Kinetic Image Cytometer, KIC) that sets the standard in high-content cellular imaging, capturing subtle disease effects with single-cell precision across kinetic (time-resolved) cellular assays, used by pharmaceutical and biotech researchers for drug discovery.
• CyteSeer Software Software platform that enables advanced single-cell analysis, revealing detailed cellular dynamics and subtle disease effects from high-content kinetic image data captured by the KIC instrument, used by researchers to characterize cellular responses.
• ValaSIM Software offering high-resolution 3D imaging with low phototoxicity, optimized for capturing complex structures such as organoids and 3D cell models in live-cell assays, used by researchers running 3D in vitro disease models.
• ValaDATE.AI AI-powered drug discovery platform that transforms kinetic cellular signals into precise, actionable insights from every drug-treated cell, integrated with the KIC instrument and proph𝔼CG assay for cardiotoxicity screening, used by pharmaceutical safety researchers.
• proph𝔼CG Assay Cardiotoxicity assay used with ValaDATE.AI that delivers high-accuracy prediction of drug-induced cardiotoxicity in preclinical drug safety screening, sold to researchers running cardiac safety studies.
• Cardiac Safety Screening Service Contract research service delivering cardiac safety assessment for pharmaceutical clients using ValaDATE.AI with proph𝔼CG to provide high-accuracy cardiotoxicity prediction in preclinical drug safety screening.
• Neuroscience Applications Service Contract research service that applies high-content kinetic screening techniques to model neurodegenerative diseases and screen compounds for neurotoxicity, provided to pharmaceutical and academic neuroscience researchers.
• High-Content Analysis Service Contract research service that delivers advanced high-content analysis to assess drug efficacy and safety, providing precise single-cell insights for preclinical research clients.

Quantifiable outcome

• Unmatched accuracy in cardiotoxicity prediction for drug safety screening

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Molecular Devices (Danaher): Market leader in high-content screening (ImageXpress) serving drug discovery researchers. Directly competes with Vala's KIC instrument and CyteSeer software in cellular imaging and analysis workflows.
• Sartorius (Essen BioScience): Through the Essen BioScience acquisition, Sartorius offers the Incucyte live-cell imaging platform. Closely comparable to Vala's kinetic, live-cell imaging approach for pharma researchers.
• Yokogawa Electric (CellVoyager): Sells the CellVoyager high-content screening system for live-cell imaging. Competes head-to-head with KIC in single-cell kinetic imaging workflows for drug discovery.
• Nanion Technologies: Provides cardiotoxicity screening instrumentation (e.g., CardioExcyte 96) for hiPSC-derived cardiomyocytes. Closely comparable to Vala's cardiac safety screening focus and contract research offering.

Broad incumbents

• Thermo Fisher Scientific: Operates Cellomics high-content screening and a broad life sciences instruments and CRO portfolio. Comparable in target customer (pharma/biotech researchers) and overlapping product categories in imaging and cell analysis.
• PerkinElmer (Revvity): Provides high-content screening instruments (Operetta), imaging software, and reagents, plus contract research services. Overlaps with Vala across instruments, software, and preclinical drug safety offerings.
• BICO (CELLINK): Bioprinting and life science tools company with expanding presence in cell biology, organoids, and lab automation. Adjacent competitor in 3D cell models and organoid workflows overlapping with ValaSIM.
• Charles River Laboratories: Large preclinical CRO offering cardiac safety and neuroscience assessment services. Comparable to Vala's contract research arm, though at much greater scale and broader scope.

Emerging players

• Axion Biosystems: Offers functional cell analysis platforms (Maestro) for cardiomyocyte and neural assays. Comparable in hiPSC-derived cardiac and neuro screening use cases, though with MEA-based rather than imaging-based readouts.
• CytoSMART Technologies: Provides compact live-cell imaging devices with cloud-based AI analysis. Adjacent in cellular kinetic imaging and AI analytics, though positioned at smaller scale than Vala's enterprise KIC platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/valasci
• LinkedInlinkedin.com/company/vala-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vala Sciences